Islet Management, LP Ironwood Pharmaceuticals Inc Transaction History

Islet Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$10.86 - $13.95 $6.52 Million - $8.37 Million	-600,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.92 - $13.92 $1.19 Million - $1.39 Million	100,000 Added 20.0%	600,000 $7.84 Million
Q2 2021 Aug 16, 2021	SELL	$10.16 - $13.11 $4.06 Million - $5.24 Million	-400,000 Reduced 44.44%	500,000 $6.44 Million
Q1 2021 May 17, 2021	BUY	$9.04 - $11.86 $1.81 Million - $2.37 Million	200,000 Added 28.57%	900,000 $10.1 Million
Q4 2020 Feb 16, 2021	BUY	$9.05 - $12.2 $6.34 Million - $8.54 Million	700,000 New	700,000 $7.97 Million
Q3 2020 Nov 16, 2020	SELL	$8.99 - $10.74 $4.5 Million - $5.37 Million	-500,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$9.14 - $11.97 $4.57 Million - $5.99 Million	500,000 New	500,000 $5.16 Million

236

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $607M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Islet Management, LP, based on Form 13F filings with the SEC.

Stay updated on Islet Management, LP with notifications on news.